CE Mark Clinical Trial Of Echo Therapeutics Symphony® CGM System

Needle-free glucose monitoring device company Echo Therapeutics, Inc. has announced that it is initiating a multi-center clinical trial of its Symphony CGM System to support a CE Mark submission. The Company expects to enroll patients over the coming weeks and announce the results of the study in the third quarter of 2013.

Echo SymphonyEcho Therapeutics Initiates CE Mark Clinical Trial of its Symphony® CGM System (via PR Newswire)

Download image PHILADELPHIA, June 5, 2013 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its needle-free Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is initiating a multi-center clinical trial of its…

published: June 6, 2013 in: Clinical Studies/Trials, Monitoring

Most read

Latest

^